• Chromosome Analysis, Body Fluid
  • Williams Syndrome, 7q11.23 Deletion
  • Vascular Endothelial Growth Factor (VEGF)
  • Cytochrome P450 1A2 (CYP1A2) Genotyping
  • Selenium, Random, Urine
  • 1,3-Beta-D-Glucan (Fungitell® ß-D Glucan), Bronchial Wash
  • Amphetamine, Serum
  • PM-1 (PM-Scl) Antibody
  • Fibroblast Growth Factor 23 (FGF23), Plasma
  • Complement Component C3, Nephritic Factor
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /Prolyl Hydroxylase Domain-2 (PHD2/EGLN1) Gene Mutation Analysis
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • ICD10
  • Additional ICD10
  • References

Prolyl Hydroxylase Domain-2 (PHD2/EGLN1) Gene Mutation Analysis
Medical Test

Diseases (2)
Access to Prolyl Hydroxylase Domain-2 (PHD2/EGLN1) Gene Mutation Analysis is restricted.
Loading...